FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to obstetrics and gynaecology, can be used in clinical nephrology and concerns a method of treating pregnant women with stage 4 chronic kidney disease. Additionally, starting from 12th week, preparations of ketone analogues of amino acids are used in dose of 6 tablets in 3 divided doses with food and acetylsalicylic acid in dose of 150 mg a day in the morning once, under daily control of blood pressure and proteinuria level twice a month. Every month, the patient undergoes blood analysis for creatinine, urea, potassium with assessment of glomerular filtration rate according to CKD-EPI. At the same time, if according to the results of the monthly analyses, there is no increase in creatinine, urea and potassium, absence of glomerular filtration rate decrease in comparison with the data obtained before the beginning of treatment, the treatment regimen is prolonged, leaving unchanged for another 1 month. If the results of the monthly analyses show no stabilization of parameters of nitrogenous wastes and a decrease in the glomerular filtration rate compared to the data obtained before the beginning of the treatment, the therapeutic regimen includes dipyridamole up to 75 mg a day. Treatment according to the above schemes is carried out till 37th week of pregnancy, and after 37th week of pregnancy, the preparation of ketone analogues of amino acids is left.
EFFECT: use of the method allows prolonging pregnancy up to 38 weeks in patients with chronic renal diseases of stage 4 and maintaining their function and survival rate, to give birth to a full-term mature baby not in need of nursing and resuscitation.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATMENT OF PATIENTS WITH CHRONIC KIDNEY DISEASE C3-C5 AT DIALYSIS STAGE, EXCLUDING PYELONEPHRITIS, UROLITHIASIS | 2017 |
|
RU2646467C1 |
METHOD OF ASSESSING EFFECTIVENESS OF VITAMIN D THERAPY FOR CHRONIC KIDNEY DISEASE IN PERSON WITH DIABETES MELLITUS | 2022 |
|
RU2806735C1 |
METHOD FOR DETERMINATION OF THE TREATMENT ONSET BY PROGRAM HEMODIALYSIS OF PATIENTS WITH CKD C5 | 2017 |
|
RU2653819C1 |
METHOD FOR PREECLAMPSIA DIAGNOSTICS IN PREGNANT WOMEN WITH CHRONIC KIDNEY DISEASE | 2016 |
|
RU2623057C1 |
METHOD FOR EARLY DIAGNOSIS OF ENDOTHELIAL RENAL DYSFUNCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2020 |
|
RU2767701C1 |
METHOD FOR EARLY DIAGNOSTICS OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2016 |
|
RU2647327C2 |
METHOD OF ASSESSING EFFECTIVENESS OF NEPHROPROTECTIVE THERAPY IN HYPERTENSIVE PATIENTS WITH STAGE C2 CHRONIC KIDNEY DISEASE | 2023 |
|
RU2810453C1 |
METHOD FOR FETOPLACENTAL INSUFFICIENCY PREVENTION FOR PREGNANT WOMEN WITH CHRONIC KIDNEY DISEASE | 2016 |
|
RU2623064C1 |
METHOD OF EARLY DIAGNOSTICS OF KIDNEY DAMAGE IN PATIENTS WITH THE INITIAL STAGE OF CHRONIC KIDNEY DISEASE | 2018 |
|
RU2677289C1 |
METHOD FOR DIAGNOSING EARLY CHRONIC RENAL DISEASE IN CHILDREN | 2020 |
|
RU2753581C1 |
Authors
Dates
2024-05-28—Published
2023-10-19—Filed